Effects of breast cancer on chronic disease medication adherence among older women
- 15 February 2016
- journal article
- research article
- Published by Wiley in Pharmacoepidemiology and Drug Safety
- Vol. 25 (8) , 898-907
Abstract
Purpose The purpose of this study was to determine the effects of breast cancer on chronic disease medication adherence among older women. Methods The Surveillance, Epidemiology, and End Results (SEER)-Medicare-linked data and a 5% random sample of Medicare enrollees were used. Stage I–III breast cancer patients diagnosed in 2008 and women without cancer were eligible. Three cohorts of medication users 66+ years were identified using diagnosis codes and prescription fill records: diabetes, hypertension, and lipid disorders. For each cohort, breast cancer patients were frequency matched to comparison women by age and geographic area. Medication adherence was measured by the proportion of days covered and medication persistence. Results During the post-baseline period, the percentage of breast cancer patients who were non-adherent was 26.2% for diabetes medication, 28.9% for lipid-lowering medication, and 14.2% for hypertension medication. Breast cancer patients experienced an increased odds of diabetes medication non-adherence [odds ratio (OR) = 1.44; 95% confidence interval (CI) = 1.07 to 1.95] and were more likely to be non-persistent with diabetes medication (hazard ratio = 1.31; 95%CI: 1.04 to 1.66) relative to women without cancer. The study failed to show a difference between breast cancer and comparison women in the odds of non-adherence to hypertensive (OR = 0.87; 95%CI: 0.71 to 1.05) or lipid-lowering medication (OR = 0. 91; 95%CI: 0.73 to 1.13) with a proportion of days covered threshold of 80%. Conclusion Special attention should be given to the coordination of primary care for older breast cancer patients with diabetes. Copyright © 2016 John Wiley & Sons, Ltd.Keywords
This publication has 23 references indexed in Scilit:
- Adjuvant Tamoxifen Influences the Lipid Profile in Breast Cancer PatientsBreast Care, 2014
- Metformin: Are Potential Benefits on Cancer Risk Extended to Cancer Survival?The Oncologist, 2013
- Metformin: an old but still the best treatment for type 2 diabetesDiabetology & Metabolic Syndrome, 2013
- Changes in adherence to statins and subsequent lipid profiles during and following breast cancer treatmentBreast Cancer Research and Treatment, 2013
- The effect of exemestane, anastrozole, and tamoxifen on lipid profiles in Japanese postmenopausal early breast cancer patients: final results of National Surgical Adjuvant Study BC 04, the TEAM Japan sub-studyAnnals of Oncology, 2011
- Adverse Selection In The Medicare Prescription Drug ProgramHealth Affairs, 2009
- Medication nonadherence is associated with a broad range of adverse outcomes in patients with coronary artery diseaseAmerican Heart Journal, 2008
- Competing Causes of Death From a Randomized Trial of Extended Adjuvant Endocrine Therapy for Breast CancerJNCI: Journal of the National Cancer Institute, 2008
- Effect of Medication Nonadherence on Hospitalization and Mortality Among Patients With Diabetes MellitusArchives of internal medicine (1960), 2006
- Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood PressureHypertension, 2003